Back to Search
Start Over
Incidence of second primary malignancy (SPM) in melphalan-prednisone-lenalidomide combination followed by lenalidomide maintenance (MPR-R) in newly diagnosed multiple myeloma patients (pts) age 65 or older
- Publication Year :
- 2011
- Subjects :
- Health Sciences
Επιστήμες Υγείας
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.dedup.wf.001..1762fd8082b613986c039f42184571ad